Skip to main content
Home

Breadcrumb

  1. Home
  2. Lucida Medical

Lucida Medical

Lucida Medical’s AI-based software , Pi, enables radiologists to find prostate cancer precisely and fast, by analysing routine MRI scans. Pi is CE marked for use in the UK and Europe, and is deployed at sites across the NHS and in 11 countries.

Lucida Medical
Healthcare, Life Science and Biotech
Future Business Centre
Cambridge
CB4 2HY
View on google maps
Membership type:
Corporate 6-20

Latest updates


Lucida Medical News
02 Apr 2026 Lucida Medical raises £8.7m to power ‘same day’ cancer diagnosis
News
28 Feb 2025 AI matches the accuracy of expert radiologists to detect prostate cancer in a major multi-centre clinical study
News
13 Nov 2024 Appointment of new Vice President of Sales and Marketing at Lucida Medical
News
06 Sep 2021 Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce major study on AI for prostate cancer
View all updates
Lucida Medical News
02 Apr 2026 Lucida Medical raises £8.7m to power ‘same day’ cancer diagnosis
News
28 Feb 2025 AI matches the accuracy of expert radiologists to detect prostate cancer in a major multi-centre clinical study
News
13 Nov 2024 Appointment of new Vice President of Sales and Marketing at Lucida Medical
News
06 Sep 2021 Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce major study on AI for prostate cancer
View all news

Stay up to date with Lucida Medical

Login or create a free user account to follow this company and see updates on your dashboard.

Create account

Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS